Terms: = Leukemia AND MLLT1, ENL, 4298, ENSG00000130382, Q03111, YEATS1, LTG19 AND Diagnosis
14 results:
1. The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in
Park SH; You E; Park CJ; Jang S; Cho YU; Yoon CH; Koh KN; Im HJ; Seo JJ
Ann Lab Med; 2019 Jul; 39(4):358-366. PubMed ID: 30809981
[TBL] [Abstract] [Full Text] [Related]
2. The incidence and distribution characteristics of MLL rearrangements in Chinese acute myeloid leukemia patients by multiplex nested RT-PCR.
Yang H; Cao T; Gao L; Wang L; Zhu C; Xu Y; Jing Y; Zhu H; Lv N; Yu L
Technol Health Care; 2017 Jul; 25(S1):259. PubMed ID: 28582914
[TBL] [Abstract] [Full Text] [Related]
3. [Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].
Nasedkina TV; Ikonnikova AY; Tsaur GA; Karateeva AV; Ammour YI; Avdonina MA; Karachunskii AI; Zasedatelev AS
Mol Biol (Mosk); 2016; 50(6):968-977. PubMed ID: 28064313
[TBL] [Abstract] [Full Text] [Related]
4. [Application of multiplex nested RT- PCR assay for screening the fusion genes in acute myeloid leukemia and its clinical significance].
Xu Y; Gao L; Sun J; Ding Y; Xu Y; Lyu C; Liu W; Wang N; Wang L; Yu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):29-34. PubMed ID: 24602728
[TBL] [Abstract] [Full Text] [Related]
5. Significance of CD66c expression in childhood acute lymphoblastic leukemia.
Kiyokawa N; Iijima K; Tomita O; Miharu M; Hasegawa D; Kobayashi K; Okita H; Kajiwara M; Shimada H; Inukai T; Makimoto A; Fukushima T; Nanmoku T; Koh K; Manabe A; Kikuchi A; Sugita K; Fujimoto J; Hayashi Y; Ohara A
Leuk Res; 2014 Jan; 38(1):42-8. PubMed ID: 24231528
[TBL] [Abstract] [Full Text] [Related]
6. The MLL recombinome of acute leukemias in 2013.
Meyer C; Hofmann J; Burmeister T; Gröger D; Park TS; Emerenciano M; Pombo de Oliveira M; Renneville A; Villarese P; Macintyre E; Cavé H; Clappier E; Mass-Malo K; Zuna J; Trka J; De Braekeleer E; De Braekeleer M; Oh SH; Tsaur G; Fechina L; van der Velden VH; van Dongen JJ; Delabesse E; Binato R; Silva ML; Kustanovich A; Aleinikova O; Harris MH; Lund-Aho T; Juvonen V; Heidenreich O; Vormoor J; Choi WW; Jarosova M; Kolenova A; Bueno C; Menendez P; Wehner S; Eckert C; Talmant P; Tondeur S; Lippert E; Launay E; Henry C; Ballerini P; Lapillone H; Callanan MB; Cayuela JM; Herbaux C; Cazzaniga G; Kakadiya PM; Bohlander S; Ahlmann M; Choi JR; Gameiro P; Lee DS; Krauter J; Cornillet-Lefebvre P; Te Kronnie G; Schäfer BW; Kubetzko S; Alonso CN; zur Stadt U; Sutton R; Venn NC; Izraeli S; Trakhtenbrot L; Madsen HO; Archer P; Hancock J; Cerveira N; Teixeira MR; Lo Nigro L; Möricke A; Stanulla M; Schrappe M; Sedék L; Szczepański T; Zwaan CM; Coenen EA; van den Heuvel-Eibrink MM; Strehl S; Dworzak M; Panzer-Grümayer R; Dingermann T; Klingebiel T; Marschalek R
Leukemia; 2013 Nov; 27(11):2165-76. PubMed ID: 23628958
[TBL] [Abstract] [Full Text] [Related]
7. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract] [Full Text] [Related]
8. Development of a biochip-based assay integrated in a global strategy for identification of fusion transcripts in acute myeloid leukemia: a work flow for acute myeloid leukemia diagnosis.
Giusiano S; Formisano-Tréziny C; Benziane A; Maroc N; Picard C; Hermitte F; Taranger-Charpin C; Gabert J
Int J Lab Hematol; 2010 Aug; 32(4):398-409. PubMed ID: 19930410
[TBL] [Abstract] [Full Text] [Related]
9. [Characteristics of fusion gene and immunophenotype in MLL gene rearrangement positive childhood acute lymphoblastic leukemia].
Gao C; Zhao W; Liu Y; Gong WY; Li WJ; Li ZG; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1283-8. PubMed ID: 19840468
[TBL] [Abstract] [Full Text] [Related]
10. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.
Burmeister T; Meyer C; Schwartz S; Hofmann J; Molkentin M; Kowarz E; Schneider B; Raff T; Reinhardt R; Gökbuget N; Hoelzer D; Thiel E; Marschalek R
Blood; 2009 Apr; 113(17):4011-5. PubMed ID: 19144982
[TBL] [Abstract] [Full Text] [Related]
11. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.
Jansen MW; Corral L; van der Velden VH; Panzer-Grümayer R; Schrappe M; Schrauder A; Marschalek R; Meyer C; den Boer ML; Hop WJ; Valsecchi MG; Basso G; Biondi A; Pieters R; van Dongen JJ
Leukemia; 2007 Apr; 21(4):633-41. PubMed ID: 17268512
[TBL] [Abstract] [Full Text] [Related]
12. [Analysis of chromosome translocations involving MML by hybridization with an oligonucleotide microarray].
Mitiaeva ON; Nasedkina TV; Zharinov VS; Isaeva EA; Turygin AIu; Chupeeva VV; Kreĭndlin EIa; Mirzabekov AD
Mol Biol (Mosk); 2004; 38(3):449-56. PubMed ID: 15285614
[TBL] [Abstract] [Full Text] [Related]
13. Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.
Blanco JG; Dervieux T; Edick MJ; Mehta PK; Rubnitz JE; Shurtleff S; Raimondi SC; Behm FG; Pui CH; Relling MV
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10338-43. PubMed ID: 11526240
[TBL] [Abstract] [Full Text] [Related]
14. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
Butler LH; Slany R; Cui X; Cleary ML; Mason DY
Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
[TBL] [Abstract] [Full Text] [Related]
